logo
← Back to all media

US election calms biotech investor jitters

The result of the U.S. election has reduced some of the uncertainty around the outlook for the biotech sector. Leading up to the election, investors felt jittery about the potential impact of the Democrats making a clean sweep – i.e. winning the Presidency, the House and the Senate. However, the odds are currently in favour of the Senate remaining Republican, reducing the likelihood of major healthcare reform.

Published on 21st December 2020

Human cell under microscope
Human cell under microscope

Disclaimer

The information on this website may only be suitable for certain types of investors and is not intended to be used or relied upon by any other person.

An investment with IBT may contain significant risks and is intended only for sophisticated investors who meet certain eligibility criteria.

The material on this website is intended to be viewed only by persons resident in the EEA.

The information on this website is not an offer to sell or a solicitation of an offer and does not constitute investment advice.

No representation, warranty or undertaking, express or implied, is given as to the accuracy or completeness of the information or opinions contained therein.

The information on this website may constitute financial promotion for the purposes of the Financial Services and Markets Act 2000 (“FSMA”).


I do not accept →